In May 2026, one of the most common hormonal conditions affecting women — long known as polycystic ovary syndrome, or PCOS — was formally renamed. The new name, polyendocrine metabolic ovarian syndrome (PMOS), followed fourteen years of global consultation and reflects something clinicians have understood for a while: this was never really a condition about ovarian cysts.
A Name Fourteen Years in the Making
The rename wasn't a branding decision. It followed a global consensus process led by Professor Helena Teede at Monash University, alongside the International Androgen Excess and Polycystic Ovary Syndrome Society (AE-PCOS Society), involving 56 patient and professional organisations — including the Endocrine Society — more than 22,000 survey responses, and multiple international workshops with patients and health professionals. The findings were published in The Lancet on 12 May 2026.
Why "Polycystic Ovary Syndrome" Was Misleading
The old name implied the condition was defined by cysts on the ovaries. It isn't. What ultrasounds actually show are small antral follicles — immature follicles that haven't matured properly, not cysts in a clinical sense. A related study published alongside the renaming found no increase in genuine ovarian cysts in people with the condition. According to the consensus authors, the old name obscured the condition's diverse endocrine and metabolic features and contributed to delayed diagnosis, fragmented care and stigma.
What PMOS Actually Stands For
PMOS — polyendocrine metabolic ovarian syndrome — is deliberately built to communicate more than the old acronym did. "Polyendocrine" points to the involvement of multiple hormone systems, not just the ovaries. "Metabolic" names the insulin, weight and cardiometabolic dimensions that are often central to the condition. "Ovarian" is retained because reproductive effects — irregular ovulation, fertility considerations — remain a real and important part of the picture, just no longer the whole story.
What Changes for You (and What Doesn't) Right Now
If you were previously diagnosed with PCOS, nothing about your underlying condition has changed — only its name and the framing clinicians use to describe it. The transition is being rolled out globally over three years, with full adoption expected in the 2028 update to the international guideline for the condition. In practice, this means you're likely to see both "PCOS" and "PMOS" used interchangeably for some time yet, in research, in clinics and online, while the new terminology becomes standard.
The Whole-Body View: Beyond the Ovaries
PMOS is now more clearly framed as a condition involving hormonal, metabolic, reproductive, dermatological and psychological health — not a single-organ diagnosis. This matters clinically because it supports looking beyond the reproductive system: insulin sensitivity, cardiovascular risk factors, skin and hair symptoms, and mental health are all recognised as part of what comprehensive care should consider, rather than side issues to the "real" diagnosis.
Where Yoga Therapy May Responsibly Support PMOS
None of this changes what a thoughtful, evidence-aware yoga practice can realistically offer. As with PCOS before it, a PMOS-aware approach tends to focus on consistency over intensity: regular, moderately active movement to support insulin sensitivity; nervous-system regulation, given the documented links between chronic stress and ovulatory hormones; and a sustainable practice a woman can actually stick with, rather than an aggressive protocol built around a single symptom.
What Yoga Therapy Cannot Do
It's worth being as direct here as we would be about the old terminology: yoga does not treat, cure or reverse PMOS, whatever it's called, and it isn't a substitute for medical diagnosis, monitoring or treatment. What a considered practice can offer is support for the parts of daily life the condition affects — stress, movement, sleep, body awareness — alongside, not instead of, appropriate medical care.
What This Means Going Forward
A name change of this scale, agreed by dozens of professional and patient organisations worldwide, is a meaningful acknowledgement that this condition was underestimated for a long time. For anyone living with it, the more useful takeaway may simply be this: the shift toward whole-body, endocrine-and-metabolic-first thinking was already happening in good clinical care, and the new name gives that shift an accurate label.
Evidence & Further Reading
The information above reflects the published consensus process and its accompanying coverage from major medical institutions. Terminology adoption is ongoing worldwide, and both names may appear in circulation for some years yet.
- Polyendocrine Metabolic Ovarian Syndrome, the New Name for Polycystic Ovary Syndrome: A Multistep Global Consensus ProcessThe Lancet, May 2026
- Polyendocrine Metabolic Ovarian Syndrome: New Name to Improve Diagnosis and CareEndocrine Society, 12 May 2026
- PCOS Is Now PMOS: Understanding the Name ChangeAmerican Society for Reproductive Medicine
- Polyendocrine Metabolic Ovarian Syndrome (PMOS)Johns Hopkins Medicine
- Polyendocrine Metabolic Ovarian Syndrome, the New Name for Polycystic Ovary SyndromePubMed
- 2023 International Evidence-Based Guideline for the Assessment and Management of PCOSESHRE / ASRM / international consensus guideline, still the active clinical guideline during transition
This is a short list of key sources, not a complete bibliography, and coverage of a name change this recent will continue to evolve. If you're making a personal health decision, please speak with a qualified doctor about what applies to you.
If PMOS — formerly known as PCOS — is part of your health picture and you'd like a clearer sense of how yoga therapy might responsibly fit in, our team is happy to talk it through.
Request a Health Consultation